The Commission on Cancer, a national consortium of organizations dedicated to improving survival rates and quality of life for cancer patients, has recognized Cedars-Sinai's Samuel Oschin Comprehensive Cancer Institute as one of nation's foremost cancer programs.
As a commission-accredited cancer program, Cedars-Sinai demonstrates that it provides its patients with access to the most current clinical trials, newest treatment options, comprehensive and multidisciplinary care, as well as the latest equipment and services.
Each cancer program evaluated by the commission must meet 36 rigorous standards for accreditation. Cedars-Sinai met or exceeded each requirement, leading to its receiving an Accreditation with Commendation. Fewer than half of the commission-accredited cancer programs receive this high designation.
"This recognition shows the cancer community and all cancer patients that we maintain the highest dedication to optimal care on every level," said Steven Piantadosi, MD, PhD, Phase One Foundation chair and director of the Samuel Oschin Comprehensive Cancer Institute .
Liver cells effectively serve as immune checkpoint regulating anti-cancer immunity